- Brubaker PL, Crivici A, Izzo A, Ehrlich P, Tsai CH, Drucker DJ. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology 1997; 138:4837-43.
- Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sei USA. 1996;93:7911-6.
- Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;273:E77-84.
- Brubaker PL, Izzo A, Hill M, Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide2. Am J Physiol 1997;272:E1050-8.
- Scott RB, Kirk D, MacNaughton WK, Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 1998;275:G911-21.
- Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806-15.
- Jeppesen PB, Mortensen PB. Intestinal failure denned by measurements of intestinal energy and wet weight absorption. Gut 2000:46:701-6.
- WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, 843. Geneva. 1994.
- Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 2000;119:639-46.
- Hartmann B, Johnsen AH, Orskov C, Adelhorst K, Thim L, Holst JJ. Structure, measurement, and secretion of human glucagonlike peptide-2. Peptides 2000;21:73-80.
- Gochman N, Givdber H. Automated, simultaneous microdetermination of calcium and magnesium by atomic absorption. Clin Chem 1970:16229-34.
- Pybus J. Determination of calcium and magnesium in serum and urine by atomic absorption spectrophotometry. ClinChim Acta 1969:23:309-17.
- Gimblet EG, Mamey AF, Bonsnes RW. Determination of calcium and magnesium in serum, urine, diet, and stool by atomic absorption spectrophotometry. Clin Chem 1967;13:204-14.
- Gamero P, Delmas PD. Bone markers. Baillieres Clin Rheumatol 1997:11:517-37.
- Kollerup G, Thamsborg G, Bhatia H, Sorensen OH. Quantitation of urinary hydroxypyridiniu m cross-links from collagen by highperformance liquid chromatography. Scand J Clin Lab Invest 1992:52:657-62.
- Lund B, Sorensen OH. Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 1979:39:23-30.
- Lund B, Sorensen OH. Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1 alpha-hydroxycholecalciferol. Acta Endocrinol Copenh 1979:91:338-50.
- Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet 1978; 1:9-12.
- Compston JE, Horton LW, Laker MF, Avers AB, Woodhead JS, Bull HJ. Bone disease after jejuno-ileal bypass for obesity. Lancet 1978;2:1-4.
- Hylander E, Ladefoged K, Madsen S. Calcium balance and bone mineral content following small-intestinal resection. Scand J Gastroenterol 1981;16:167-76.
- Krawitt EL, Beeken WL, Janney CD. Calcium absorption in Crohn's disease. Gastroenterology 1976;71:251-4.
- Booth CC, Madntyre I, Mollin DL. Nutritional problems associated with extensive lesions of the distal small intestine in man. Q J Med 1964;33:401-20.
- Thompson GR, Lewis B, Booth CC. Absorption of vitamin D33H in control subjects and patients with intestinal malabsorption. J Clin Invest 1966;45:94-102.
- Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 1985:42:644-9.
- Driscoll RH, Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982:83:1252-8.
- Shike M, Harriso n JE, Sturtridge WC, Tarn CS, Bobechko PE, Jones G. Metabolie bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 1980:92:343-50.
- Baron R. Anatomy and ultrastructure of bone. In: Murray JF, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research; 1990. p. 3-26.
- Basha B, Rao DS, Han ZH, Parfitt AM. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 2000:108:296-300.
- Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its collection. J Bone Miner Res 1995:10:1753-61.
- Drucker DJ. Glucagon-like Peptide 2. Trends Endocrinol Metab 1999:10:153-6.
- Sogaard CH, Mosekilde L, Thomsen JS, Richards A, McOsker JE. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model. Bone 1997:20:439-49.
- Sugimoto T, Nakaoka D, Nasu M, Kanzawa M, Sugishita T, Chihara K. Effect of recombinant human growth hormone in elderly osteoporotic women. Clin Endocrinol (Oxf) 1999;51 : 715-24.
- Robinson RJ, Zywicki T, Almond L, al Azzawi F, Abrams K, Iqbal SJ. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998:115:36-41.
- Jensen LB, Quaade F, Sorensen OH. Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 1994:9:459-63.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 4